Search results - 30 results
A multinational report to characterise SARS-CoV-2 infection in people with cystic fibrosis
versions: DOI: https://doi.org/10.1016/j.jcf.2020.04.012 File: Version: Published Full text access: Public Access Full text language: English Category: A1 FOS Classification: 3.02 Clinical medicine ...
The Belgian Cystic Fibrosis Registry- Facts and highlights 2017
https://www.sciensano.be/en/biblio/belgian-cystic-fibrosis-registry-facts-and-hi… File: Version: Published Full text access: Public Access Full text language: English Category: F21 FOS Classification: 3.02 Clinical medicine ...
Risk factors and impact of allergic bronchopulmonary aspergillosis in Pseudomonas aeruginosa-negative CF patients.
BACKGROUND: Allergic bronchopulmonary aspergillosis (ABPA) is a major complication in cystic fibrosis (CF) patients. Risk factors for ABPA and clinical deterioration in CF patients, negative for Pseudomonas ...
The Belgian Cystic Fibrosis Registry- Facts and highlights 2016
Access Full text language: English Category: F35 FOS Classification: 3.02 Clinical medicine 3.05 Other medical sciences ...
Le registre belge de la mucoviscidose- Faits et chiffres 2016
F35 FOS Classification: 3.02 Clinical medicine ...
Belgisch mucoviscidose register- Feiten en cijfers 2016
FOS Classification: 3.02 Clinical medicine ...
EPS5.06 Demography and clinical outcomes in cystic fibrosis lung transplant recipients in Belgium
Version: Published Full text access: Public Access Full text language: English Category: P1 FOS Classification: 3.02 Clinical medicine ...
Annual report Belgian Cystic Fibrosis Registry 2012
access: Public Access Full text language: English Category: E11 FOS Classification: 3.02 Clinical medicine ...
Inhaled corticosteroids and lower lung function decline in young children with cystic fibrosis.
File: Version: Published Full text access: Public Access Full text language: English Category: A1 FOS Classification: 3.02 Clinical medicine ...
Factors associated with clinical progression to severe COVID-19 in people with cystic fibrosis: A global observational study.
introduction of vaccines were included. It was de-identified and included patient demographics, clinical characteristics, treatments, outcomes and sequalae following SARS-CoV-2 infection. Multivariable logistic ...